-
Assessing Productivity in Health Technology Assessment: A Comparative Review of Human Capital and Friction Cost Approaches in Europe
Sep 9, 2025, 16:22 PM -
Design Operating Characteristics in a Noninterventional Study Framework
Sep 9, 2025, 16:22 PM -
Activity of the French Economic and Public Health Evaluation Committee (CEESP): Retrospective of 10 Years of Economic Assessment on Health Products
Sep 9, 2025, 16:22 PM -
Health Utility Values in Adults With Primary Biliary Cholangitis: A Global Systematic Literature Review
Sep 9, 2025, 16:22 PM -
An Algorithm to Identify Immunocompromised Patients in French Claims Data for Rapid Preventive or Therapeutic Interventions
Sep 9, 2025, 16:22 PM -
The Growing Importance of Reserve Antibiotics in Organ Transplant Care and the Role of Timely Appropriate Antibiotic Treatment to Preserve the Benefits of Prior Health Investments
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Patient-Reported Outcomes (PROs) in Asthma Biologic Late-Phase Studies and Approved Labels: Implications for Entry and Product Differentiation
Sep 9, 2025, 16:22 PM -
Assessing the Cost-Effectiveness of Subcutaneous Semaglutide 2.4 mg in the Management of Individuals With Obesity and Prediabetes in England
Sep 9, 2025, 16:22 PM -
The Impact of Network Meta-Analyses on HTA Decisions in Oncology: A Review of NICE Appraisals
Sep 9, 2025, 16:22 PM -
Gender Differences in the Economic Burden of Alcohol Use in Belgium
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis (CUA) of Sepiapterin for Treatment of Phenylketonuria (PKU)
Sep 9, 2025, 16:22 PM -
Lifetime Secondary Healthcare Resource Utilization in Phenylketonuria From Birth to Adulthood in Sweden
Sep 9, 2025, 16:22 PM -
Cost of Illness Study: Cushing's Syndrome in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
Comorbidities and Comedication Among Individuals in Treatment for ADHD: A Danish Nationwide Study
Sep 9, 2025, 16:22 PM -
Real-World Data for External Controls: Insights From EMA Regulatory Submissions
Sep 9, 2025, 16:22 PM -
Clinical and Economic Burden Imposed by Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Belgium
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Mixed Maternal RSVpreF/Infant Nirsevimab Immunization Approach vs. Nirsevimab Alone for the Prevention of Respiratory Syncytial Virus in Chile
Sep 9, 2025, 16:22 PM -
Disability Resource Utilization and Caregiver Support Among a Real-World Sample of Patients With Transthyretin Amyloidosis With Polyneuropathy
Sep 9, 2025, 16:22 PM -
Preferences for a Combination Influenza and COVID-19 Vaccine: Results From a Stated-Preference Survey With Consumers in the United States, United Kingdom, and Germany
Sep 9, 2025, 16:22 PM -
APDS Treatment in Germany: Decision Criteria, Costs, and Contribution of Leniolisib to Outcomes
Sep 9, 2025, 16:22 PM
